These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26204587)

  • 21. Leveraging HIV-related human rights achievements through a Framework Convention on Global Health.
    Buse K; Eba P; Sigurdson J; Thomson K; Timberlake S
    Health Hum Rights; 2013 Jun; 15(1):E96-110. PubMed ID: 25006095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of intellectual property rights in treatment access: challenges and solutions.
    't Hoen E; Passarelli CA
    Curr Opin HIV AIDS; 2013 Jan; 8(1):70-4. PubMed ID: 23201855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal access to HIV treatment in the context of vulnerability: female farm workers in Zimbabwe.
    Bhatasara S; Chiweshe MK
    Health Care Women Int; 2015; 36(2):188-204. PubMed ID: 23919561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The social construction of ARVs in South Africa.
    Sember R
    Glob Public Health; 2008; 3 Suppl 2():58-75. PubMed ID: 19288353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
    Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
    Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluations of HIV prevention in rich countries and the need to focus on the aging of the HIV-positive population.
    Brent RJ; Brennan M; Karpiak SE
    Curr Opin HIV AIDS; 2010 May; 5(3):255-60. PubMed ID: 20539083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global access to treatment: achievements and challenges.
    Cameron E; Gupta A
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):59-71. PubMed ID: 14765514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Articulating a rights-based approach to HIV treatment and prevention interventions.
    Barr D; Amon JJ; Clayton M
    Curr HIV Res; 2011 Sep; 9(6):396-404. PubMed ID: 21999775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taking the fight to their realm: the role of patent oppositions in the struggle for access to medicines.
    Park C
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):84-5. PubMed ID: 17375435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [1986-2006: 20 years of failed international policy to control AIDS in Africa].
    Kerouedan D
    Med Trop (Mars); 2007 Oct; 67(5):515-28. PubMed ID: 18225738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
    Beaulière A; Le Maux A; Trehin C; Perez F
    Rev Epidemiol Sante Publique; 2010 Jun; 58(3):171-9. PubMed ID: 20430553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral therapy in HIV.
    Yu A; Berbari E; Temesgen Z
    J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update to international guidelines on HIV/AIDS and human rights.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):53-5. PubMed ID: 14725244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will.
    Beyrer C; Birx DL; Bekker LG; Barré-Sinoussi F; Cahn P; Dybul MR; Eholié SP; Kavanagh MM; Katabira ET; Lundgren JD; Mworeko L; Pala M; Puttanakit T; Ryan O; Sidibé M; Montaner JS;
    Lancet; 2015 Aug; 386(9993):505-7. PubMed ID: 26293427
    [No Abstract]   [Full Text] [Related]  

  • 40. International obligations through collective rights: Moving from foreign health assistance to global health governance.
    Meier BM; Fox AM
    Health Hum Rights; 2010 Jun; 12(1):61-72. PubMed ID: 20930254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.